Jihee Sohn

1.0k total citations · 1 hit paper
21 papers, 728 citations indexed

About

Jihee Sohn is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Jihee Sohn has authored 21 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Cell Biology. Recurrent topics in Jihee Sohn's work include Neurogenetic and Muscular Disorders Research (6 papers), Mesenchymal stem cell research (4 papers) and Muscle Physiology and Disorders (4 papers). Jihee Sohn is often cited by papers focused on Neurogenetic and Muscular Disorders Research (6 papers), Mesenchymal stem cell research (4 papers) and Muscle Physiology and Disorders (4 papers). Jihee Sohn collaborates with scholars based in United States, Australia and United Kingdom. Jihee Sohn's co-authors include Rocky S. Tuan, Hang Lin, He Shen, Mark T. Langhans, Natasha Baker, Madalyn R. Fritch, Ying Tang, Peter G. Alexander, Kazunori Shimomura and Yuhao Deng and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Biomaterials.

In The Last Decade

Jihee Sohn

20 papers receiving 720 citations

Hit Papers

Bone marrow mesenchymal stem cells: Aging and tissue engi... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihee Sohn United States 11 325 215 174 172 111 21 728
Tatjana Schilling Germany 14 387 1.2× 242 1.1× 184 1.1× 183 1.1× 75 0.7× 21 848
Graciosa Q. Teixeira Germany 16 302 0.9× 299 1.4× 178 1.0× 321 1.9× 100 0.9× 34 1.1k
Arantza Infante Spain 13 445 1.4× 189 0.9× 141 0.8× 105 0.6× 71 0.6× 24 809
Gerald Friedl Austria 7 267 0.8× 202 0.9× 144 0.8× 189 1.1× 70 0.6× 8 654
Zahia Hamidouche France 11 436 1.3× 169 0.8× 177 1.0× 122 0.7× 71 0.6× 15 845
Jeeranan Manokawinchoke Thailand 16 352 1.1× 169 0.8× 106 0.6× 105 0.6× 105 0.9× 44 691
Yao Sun China 16 469 1.4× 247 1.1× 116 0.7× 152 0.9× 67 0.6× 39 992
Taocong Jin United States 15 708 2.2× 212 1.0× 195 1.1× 142 0.8× 110 1.0× 21 1.3k
Chikahisa Higuchi Japan 17 487 1.5× 230 1.1× 122 0.7× 232 1.3× 282 2.5× 32 1.1k
Hannah K. Heywood United Kingdom 12 254 0.8× 239 1.1× 177 1.0× 245 1.4× 320 2.9× 16 840

Countries citing papers authored by Jihee Sohn

Since Specialization
Citations

This map shows the geographic impact of Jihee Sohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihee Sohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihee Sohn more than expected).

Fields of papers citing papers by Jihee Sohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihee Sohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihee Sohn. The network helps show where Jihee Sohn may publish in the future.

Co-authorship network of co-authors of Jihee Sohn

This figure shows the co-authorship network connecting the top 25 collaborators of Jihee Sohn. A scholar is included among the top collaborators of Jihee Sohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihee Sohn. Jihee Sohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Proud, Crystal M., Richard S. Finkel, Julie Parsons, et al.. (2025). Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy. Journal of Clinical Investigation. 135(22). 1 indexed citations
2.
Proud, Crystal M., Julie Parsons, Nancy L. Kuntz, et al.. (2024). 180P Interim results from RESPOND: a study of nusinersen in children with spinal muscular atrophy (SMA) previously treated with onasemnogene abeparvovec (OA). Neuromuscular Disorders. 43. 104441.615–104441.615. 1 indexed citations
3.
Sohn, Jihee, Jelena Milosevic, Thomas Brouse, et al.. (2022). A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis. Blood Advances. 6(8). 2557–2577. 10 indexed citations
4.
5.
Alves, Christiano R. R., Marco Petrillo, Jihee Sohn, et al.. (2021). Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: A case series. Molecular Therapy — Methods & Clinical Development. 23. 524–538. 30 indexed citations
6.
Rist, Pamela M., Varant Kupelian, Marco Petrillo, et al.. (2021). 14-Year Changes in Plasma Neurofilament Levels Among Men: A Pilot Study. Journal of Neuromuscular Diseases. 8(4). 621–624.
7.
Li, Zhong, Madalyn R. Fritch, Sachin Velankar, et al.. (2021). Caveolin-1 mediates soft scaffold-enhanced adipogenesis of human mesenchymal stem cells. Stem Cell Research & Therapy. 12(1). 347–347. 19 indexed citations
8.
Crawford, Thomas O., Kathryn J. Swoboda, Charlotte J. Sumner, et al.. (2021). SMA - TREATMENT. Neuromuscular Disorders. 31. S137–S137. 1 indexed citations
9.
Farrar, Michelle A., Francesco Muntoni, Charlotte J. Sumner, et al.. (2021). Plasma Phosphorylated Neurofilament Heavy Chain (pNF-H) Level is Associated with Future Motor Function in Nusinersen-treated Individuals with Later-onset Spinal Muscular Atrophy (SMA) (2248). Neurology. 96(15_supplement). 3 indexed citations
10.
Young, Millie, Karlla W. Brigatti, Robert M. Reed, et al.. (2021). Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy. Muscle & Nerve. 65(1). 51–59. 12 indexed citations
11.
Jiang, Yangzi, Hang Lin, He Shen, et al.. (2019). Muscle injury promotes heterotopic ossification by stimulating local bone morphogenetic protein-7 production. Journal of Orthopaedic Translation. 18. 142–153. 29 indexed citations
12.
Sohn, Jihee, et al.. (2019). What Links Neutropenia to Immature Cardiolipin in Patients with Barth Syndrome (tafazzin-deficiency)?. Blood. 134(Supplement_1). 3579–3579. 1 indexed citations
13.
Sohn, Jihee, Hang Lin, Madalyn R. Fritch, & Rocky S. Tuan. (2018). Influence of cholesterol/caveolin-1/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells. Stem Cell Research & Therapy. 9(1). 86–86. 45 indexed citations
14.
Lin, Hang, Jihee Sohn, He Shen, Mark T. Langhans, & Rocky S. Tuan. (2018). Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing. Biomaterials. 203. 96–110. 311 indexed citations breakdown →
15.
Sohn, Jihee & Johnny Huard. (2016). Sexual Dimorphism in Stem Cell–Based Therapies for the Musculoskeletal System. Operative Techniques in Orthopaedics. 26(3). 166–176. 1 indexed citations
16.
Sohn, Jihee, et al.. (2016). From embryonic development to human diseases: The functional role of caveolae/caveolin. Birth Defects Research Part C Embryo Today Reviews. 108(1). 45–64. 22 indexed citations
17.
Baker, Natasha, Jihee Sohn, & Rocky S. Tuan. (2015). Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis. Stem Cell Research & Therapy. 6(1). 238–238. 93 indexed citations
18.
Sohn, Jihee, et al.. (2015). Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice. Human Molecular Genetics. 24(13). 3814–29. 25 indexed citations
19.
Lu, Aiping, Minakshi Poddar, Ying Tang, et al.. (2014). Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin−/− mice. Human Molecular Genetics. 23(18). 4786–4800. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026